Sign in
4

Changes in Ownership

Avalo Therapeutics, Inc. Filed Acc 0001192482-21-000118

Options or other derivatives

  • Chief Scientific Officer acquired 260,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

NEIL GARRY ARTHUR · Chief Scientific Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-01-26 Grant or award : show line 1 in the form Stock Option (right to buy) +260,000 $3.32 2031-01-26 260,000 260,000 D
Loading xslF345X03/edgar.xml…